NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 3 filers reported holding NOVOCURE LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $313,358 | -27.4% | 19,403 | +86.6% | 0.00% | -20.0% |
| Q2 2023 | $431,600 | -20.3% | 10,400 | +15.6% | 0.01% | -16.7% |
| Q1 2023 | $541,260 | -95.5% | 9,000 | -94.5% | 0.01% | -95.2% |
| Q4 2022 | $12,058,739 | +11.0% | 164,400 | +15.0% | 0.12% | +6.8% |
| Q3 2022 | $10,865,000 | +10.6% | 143,000 | +1.1% | 0.12% | +19.4% |
| Q2 2022 | $9,827,000 | -45.0% | 141,400 | -34.4% | 0.10% | -43.7% |
| Q1 2022 | $17,862,000 | +8831.0% | 215,600 | +11891.1% | 0.17% | +8600.0% |
| Q3 2020 | $200,000 | +1011.1% | 1,798 | +491.4% | 0.00% | – |
| Q2 2020 | $18,000 | -94.2% | 304 | -93.4% | 0.00% | -100.0% |
| Q1 2020 | $308,000 | -80.3% | 4,580 | -90.8% | 0.00% | -80.0% |
| Q2 2018 | $1,565,000 | +43.6% | 50,000 | 0.0% | 0.02% | +42.9% |
| Q1 2018 | $1,090,000 | – | 50,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| StepStone Group LP | 115,479 | $7,302,000 | 11.05% |
| HARTLINE INVESTMENT CORP/ | 335,585 | $21,219,000 | 5.07% |
| Darsana Capital Partners LP | 1,500,000 | $94,845,000 | 3.08% |
| Rhenman & Partners Asset Management AB | 365,899 | $23,136,000 | 2.55% |
| COURAGE CAPITAL MANAGEMENT LLC | 20,000 | $1,265,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 46,599 | $2,946,000 | 2.04% |
| Granite Investment Partners, LLC | 411,659 | $26,029,000 | 1.40% |
| Nicholas Investment Partners, LP | 146,106 | $9,238,000 | 0.85% |
| Baillie Gifford | 8,829,449 | $558,287,000 | 0.59% |
| Cortina Asset Management, LLC | 141,352 | $8,938,000 | 0.55% |